Nature Reviews Cancer 影响因子、索引、排名

Nature Reviews Cancer 是一本致力于发表该领域研究成果的学术期刊 Medicine. Nature Publishing 是这本受人尊敬的期刊的出版商。. P-ISSN 分配给 Nature Reviews Cancer 是 1474-175X 它的缩写形式是 Nat Rev Cancer.

The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers tumorigenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and metastasis. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer aims to be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.

Subjects Covered:

Genomic instability: chromosomal and microsatellite instabilities, defects in DNA repair pathways. Growth promoting signals: dysregulation of growth factor signalling pathways and cell cycle progression, proto-oncogenes and their activation. Growth inhibitory signals: dysregulation of quiescence and differentiation, tumour suppressors and their inactivation. Cancer stem cells. Cell death: evading programmed cell death, including avoidance of immune surveillance systems. Metabolism: pathways of nutrient acquisition and metabolism in tumour cells and cells of the tumour microenvironment, effects of systemic metabolism on cancer initiation and progression. Tumour microenvironment:  immune and stromal cells, tumour vasculature, extracellular matrix components, cell–cell communication. Tumour evolution and heterogeneity. Metastasis:  tumour cell dissemination, dormancy and growth in new microenvironments. Carcinogenesis and cancer prevention: epidemiology, genetic and environmental triggers, gene–environment interactions, strategies for reducing risk. Cancer diagnosis and prognosis: molecular markers, diagnostic imaging, detecting minimal residual disease. New approaches to cancer therapy: rational drug design, gene therapy, immunotherapy, combination therapies, combating drug resistance, targeting therapies to the individual. Experimental systems and techniques: cell culture systems, animal and patient-derived models, genomic, epigenomic, proteomic and metabolomic approaches to studying cancer. Cancer-associated disease: cancer pain, cachexia, symptoms associated with treatment, psychosocial aspects of cancer. Ethical, legal and social issues surrounding cancer research: trial design, genetic screening, research policy, advocacy. Conventional approaches to cancer diagnosis and treatment: how do they perform, what are their drawbacks and how might they be improved in the future?

Nature Reviews Cancer 缩写 : 期刊缩写是指用于表示学术期刊完整标题的缩写形式或首字母缩略词。 它是一种常用的速记方式，有助于在学术出版物、参考书目和数据库中引用、索引和引用期刊。

的缩写 Nature Reviews Cancer 是 Nat Rev Cancer

Nature Reviews Cancer 排行 : 期刊排名是指对学术期刊进行评估和分类的过程 (Nature Reviews Cancer) 基于各种标准，例如影响因子、引用指标、专家评估和其他指标。 排名系统旨在提供期刊在特定领域或学科内的质量、影响力和声望的指示。

的排名 Nature Reviews Cancer 是 5 (2024)

Nature Reviews Cancer 影响因子 : 影响因子是用来评估学术期刊在各自领域内的影响力和重要性的指标。 它通常每年计算一次，衡量特定时期内期刊上发表的文章收到的平均引用次数。

影响因子 Nature Reviews Cancer 是 78.5 (2024)

Nature Reviews Cancer SCImago : SCImago 期刊排名 (SJR) 是由 SCImago Lab 开发的指标和数据库，提供有关学术期刊的科学影响力和声望的信息。 SCImago 是一个位于西班牙的独立研究小组，专注于科学期刊的文献计量分析和排名。

的SCImagoNature Reviews Cancer 是 20.977

Nature Reviews Cancer H指数 : 期刊 H 指数是根据学术期刊的出版物以及这些出版物获得的引用次数来衡量学术期刊的影响力和影响力的指标。 它源自作者 h 指数的概念，该指数根据单个研究人员被引用次数最多的论文来评估其影响力。

H 指数 Nature Reviews Cancer 是 484

Nature Reviews Cancer 索引 : 期刊索引是指将期刊纳入对学术出版物进行分类和组织的可搜索数据库或索引的过程。 索引服务旨在使研究人员、学者和读者更轻松地发现和访问特定领域或学科内各种期刊的文章。

这 Nature Reviews Cancer 这 索引于

• Web of Science
• UGC
• Scopus
• PubMed
• Medline
• Google Scholar

被索引的期刊表明它已经过期刊索引者的彻底审查过程，以满足特定的标准和要求。

Nature Reviews Cancer 提交费 : 文章提交费，也称为稿件提交费或处理费，是一些期刊向提交研究论文以供考虑出版的作者收取的费用。 这些费用与可能与接受的稿件相关的任何出版费或文章处理费 (APC) 是分开的。

提交费 Nature Reviews Cancer 是 €9,750 / $11,690 / £8,490

• Journal Website
• PubMed
• Scopus
• SCImago